CH380301A - Procédé de fabrication de préparations injectables d'insuline à action retardée - Google Patents

Procédé de fabrication de préparations injectables d'insuline à action retardée

Info

Publication number: CH380301A
Authority: CH; Switzerland
Prior art keywords: insulin; crystals; suspension; metal; zinc
Prior art date: 1956-12-01

Application number

CH5313757A

Other languages

English (en)

French (fr)

Inventor

Schlichtkrull Jorgen

Original Assignee

Novo Terapeutisk Labor As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1956-12-01

Filing date

1957-11-27

Publication date

1964-07-31

1957-11-27 Application filed by Novo Terapeutisk Labor As filed Critical Novo Terapeutisk Labor As

1964-07-31 Publication of CH380301A publication Critical patent/CH380301A/fr

Links

238000002360 preparation method Methods 0.000 title claims description 10
238000000034 method Methods 0.000 title claims description 7
238000004519 manufacturing process Methods 0.000 title description 5
102000016261 Long-Acting Insulin Human genes 0.000 title description 2
108010092217 Long-Acting Insulin Proteins 0.000 title description 2
229940100066 Long-acting insulin Drugs 0.000 title description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 92
102000004877 Insulin Human genes 0.000 claims description 46
108090001061 Insulin Proteins 0.000 claims description 46
239000013078 crystal Substances 0.000 claims description 46
229940125396 insulin Drugs 0.000 claims description 46
239000000725 suspension Substances 0.000 claims description 25
229910052751 metal Inorganic materials 0.000 claims description 15
239000002184 metal Substances 0.000 claims description 15
238000002425 crystallisation Methods 0.000 claims description 12
230000008025 crystallization Effects 0.000 claims description 12
239000012736 aqueous medium Substances 0.000 claims description 6
230000001737 promoting effect Effects 0.000 claims description 6
150000002500 ions Chemical class 0.000 claims description 5
241000282817 Bovidae Species 0.000 claims description 3
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
238000006243 chemical reaction Methods 0.000 claims description 3
210000004907 gland Anatomy 0.000 claims description 3
229910021645 metal ion Inorganic materials 0.000 claims description 3
RWIUTHWKQHRQNP-ZDVGBALWSA-N (9e,12e)-n-(1-phenylethyl)octadeca-9,12-dienamide Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(=O)NC(C)C1=CC=CC=C1 RWIUTHWKQHRQNP-ZDVGBALWSA-N 0.000 claims 1
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 13
229910052725 zinc Inorganic materials 0.000 description 13
239000011701 zinc Substances 0.000 description 13
239000000243 solution Substances 0.000 description 11
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
239000000203 mixture Substances 0.000 description 8
210000000496 pancreas Anatomy 0.000 description 8
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 8
239000002609 medium Substances 0.000 description 7
239000008223 sterile water Substances 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
235000015278 beef Nutrition 0.000 description 5
230000003111 delayed effect Effects 0.000 description 5
239000008174 sterile solution Substances 0.000 description 4
239000011592 zinc chloride Substances 0.000 description 4
235000005074 zinc chloride Nutrition 0.000 description 4
150000002739 metals Chemical class 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
239000007900 aqueous suspension Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000006172 buffering agent Substances 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
239000007979 citrate buffer Substances 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
GJMPSRSMBJLKKB-UHFFFAOYSA-N 3-methylphenylacetic acid Chemical compound CC1=CC=CC(CC(O)=O)=C1 GJMPSRSMBJLKKB-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
244000131522 Citrus pyriformis Species 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
150000003842 bromide salts Chemical class 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
-1 halogen ions Chemical class 0.000 description 1
150000004694 iodide salts Chemical class 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229940117957 triethanolamine hydrochloride Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CH5313757A 1956-12-01 1957-11-27 Procédé de fabrication de préparations injectables d'insuline à action retardée CH380301A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK422356A DK92662C (da)	1956-12-01	1956-12-01	Fremgangsmåde til fremstilling af protraheret virkende insulinpræparater.

Publications (1)

Publication Number	Publication Date
CH380301A true CH380301A (fr)	1964-07-31

Family

ID=8131464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH5313757A CH380301A (fr)	1956-12-01	1957-11-27	Procédé de fabrication de préparations injectables d'insuline à action retardée

Country Status (2)

Country	Link
CH (1)	CH380301A (da)
DK (1)	DK92662C (da)

1956
- 1956-12-01 DK DK422356A patent/DK92662C/da active
1957
- 1957-11-27 CH CH5313757A patent/CH380301A/fr unknown

Also Published As

Publication number	Publication date
DK92662C (da)	1962-01-29

Publication	Publication Date	Title
Hillman et al.	1956	Interaction of Manganese and 2, 4-Dichlorophenol in the Enzymatic Destruction of Indoleacetic Acid.
Finkle et al.	1954	Metabolism of Isolated Cellular Particles from Photo-synthetic Tissues: II. Oxidative decarboxylation of oxalic acid1.
US2920014A (en)	1960-01-05	Insulin crystals and preparations and processes for producing them
BE1001527A6 (fr)	1989-11-21	Preparation aqueuse stabilisee d'acide folique.
US3293143A (en)	1966-12-20	Stabilization of bromelain preparations
DE69002770T3 (de)	1998-10-15	Flüssiges enzymatisches reinigungsmittel.
FR2478658A1 (fr)	1981-09-25	Procede de preparation de colorant jaune direct 11 sous forme de solutions concentrees stables, solutions obtenues et applications
FR2823202A1 (fr)	2002-10-11	Engrais a base d'hydroxyde de cuivre ayant des proprietes fongiciels contre de nombreuses maladies cryptogamiques et un procede d'obtention d'un tel engrais
Dixon	1964	Excystment of metacercariae of Fasciola hepatica L. in vitro
KR100611561B1 (ko)	2006-08-10	NaOH와 목초액, 규산, 길경 및 키토산을 이용한 흰가루병 예방, 치료 및 억제용 살균제 조성물
US4904586A (en)	1990-02-27	Enzymatic process for treating xanthan gums in order to improve the filterability of their aqueous solutions
US4150966A (en)	1979-04-24	Method for cultivation of tobacco plants
US2269397A (en)	1942-01-06	Composition of matter
US1040665A (en)	1912-10-08	Manufacture of a stable preparation from hydrogen peroxid and urea.
US2154170A (en)	1939-04-11	Stable basic aluminum formate and solutions thereof
US2219167A (en)	1940-10-22	Process for the manufacture of preparations containing the circulatory hormone callicrein
FR2601674A1 (fr)	1988-01-22	Procede de preparation d'une solution aqueuse du sel de sodium de la methionine
US1464710A (en)	1923-08-14	Process of pretreating dried yeast to increase the baking strength
US4180626A (en)	1979-12-25	Process for manufacturing citric acid from olefins by fermentation
CH604730A5 (en)	1978-09-15	Disinfectant concentrate contg alkyl benzalkonium halides
US2166253A (en)	1939-07-18	Zinc chloride
JP2023074995A (ja)	2023-05-30	流動性に優れた腐植酸カリ水溶液組成物
AT236581B (de)	1964-10-26	Verfahren zur Herstellung von Penicillinderivaten
CH326787A (fr)	1957-12-31	Procédé de fabrication de préparations injectables d'insuline à effet prolongé
CH348399A (fr)	1960-08-31	Procédé pour la préparation d'acrylamide pratiquement exempte de fer